Metrdy offers flow cytometry researchers a curated database of validated antibody titration data and computational tools to optimize experimental design. This platform accelerates assay development by providing empirically determined antibody concentrations, improving reproducibility and signal-to-noise ratios in cellular analysis.
Funding
Funding not disclosed
Founders
Product
Problem
Flow cytometry researchers often face challenges in optimizing antibody concentrations, leading to inefficient experimental design and suboptimal data quality. This process requires extensive empirical testing, consuming valuable reagents and time, and can result in inconsistent results due to variations in antibody performance.
Solution
Metrdy provides a curated database of validated antibody titration data and a suite of computational tools to streamline experimental setup for flow cytometry. The platform offers access to empirically determined optimal antibody concentrations, reducing the need for researchers to perform de novo titrations. By leveraging this data, scientists can accelerate their experimental design, improve assay reproducibility, and enhance the signal-to-noise ratio in their cellular analysis. Metrdy's tools facilitate efficient antibody selection and optimization, ultimately leading to more reliable and interpretable experimental outcomes.
Target Audience
The primary users are academic and industry researchers, including immunologists, cell biologists, and clinical scientists, who perform flow cytometry experiments.
Features
- Curated database of validated antibody titration data for flow cytometry applications.
- Computational tools for predicting optimal antibody concentrations based on experimental parameters.
- Resources for efficient antibody selection and optimization to improve assay performance.
- Data visualization features to analyze titration curves and identify optimal working concentrations.
- Integration capabilities for importing and managing custom titration data.